Suchergebnisse - "Asselah, Tarik"

PubPharm (48)

1

What is the Path Forward to Treat Hepatitis Delta Virus? : Old Treatments and New Options

enthalten in: Clinics in liver disease | 2023

von Asselah, T.

2

Nucleic Acid Polymers are Effective in Targeting Hepatitis B Surface Antigen, but More Trials Are Needed

enthalten in: Gastroenterology | 2020

von Durantel, D. | Asselah, T.

CommentOn: Gastroenterology. 2020 Jun;158(8):2180-2194. - PMID 32147484

3

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

enthalten in: PloS one | 2020

von Marcellin, P. | Xie, Q. | Woon Paik, S. | +14

4

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4 : the ANRS HC32 QUATTRO study

enthalten in: European journal of gastroenterology & hepatology | 2018

von Roulot, D. | Thibault, V. | Laforest, C. | +17

CommentIn: Eur J Gastroenterol Hepatol. 2018 Jul;30(7):807-808. - PMID 29847527

5

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings

enthalten in: Antiviral therapy | 2018

von Lampertico, P. | Messinger, D. | Oladipupo, H. | +3

6

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

enthalten in: PloS one | 2017

von Asselah, T. | Moreno, C. | Sarrazin, C. | +12

7

Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin : Pooled Analysis of Data from Two Large, International Cohort Studies

enthalten in: Advances in therapy | 2016

von Asselah, T. | Esmat, G. | Sanai, F. | +4

8

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1 : pooled analysis of two phase 3 trials

enthalten in: Annals of hepatology | 2016

von Jensen, D. | Asselah, T. | Dieterich, D. | +27

9

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin

enthalten in: PloS one | 2016

von Asselah, T. | Thompson, A. | Flisiak, R. | +4

10

STARTVerso1 : A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection

enthalten in: Journal of hepatology | 2015

von Ferenci, P. | Asselah, T. | Foster, G. | +23

1
2
3
4
5
Nächster »
[5]